| (Values in U.S. Thousands) | Jun, 2026 | Jun, 2026 | Jun, 2026 | Jun, 2026 | Jun, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Curative Biotechnology Inc (CUBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Curative Biotechnology Inc. is a development-stage biomedical company focusing on novel treatments for rare diseases. The company is focused on therapies with potentially accelerated development paths as a result of either the disease, the nature of the therapeutic itself or the stage of clinical development. Curative Biotechnology Inc., formerly known as CONNECTYX TECHS, is based in Boca Raton, FL.
Fiscal Year End Date: 12/31